TrendFlares logo

RenovoRx, Inc. (RNXT)

$0.98 -0.61% $-0.00 Healthcare

RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, Inc. was founded in 2009 and is headquartered in Los Altos, California.

$23.60M

Mr. Shaun R. Bagai

10.00

Los Altos, CA

Aug 12, 2021

-1.64

$-0.60

3.50

3.72

0.00%

-0.68

5.57

0.00

3.50

-154.48%

-208.03%

Downtrend

Similar stocks (13)

Eledon Pharmaceuticals, Inc.

ELDN

$2.48 -0.80%
Neutral

Ikena Oncology, Inc.

IKNA

$1.71 3.01%
Neutral

Nutriband Inc.

NTRB

$5.60 10.24%
Neutral

Anebulo Pharmaceuticals, Inc.

ANEB

$2.08 4.00%
Downtrend

Tempest Therapeutics, Inc.

TPST

$1.41 0.00%
Downtrend

ARCA biopharma, Inc.

ABIO

$28.80 1,052.00%
Downtrend

Longeveron Inc.

LGVN

$2.06 0.49%
Downtrend

SAB Biotherapeutics, Inc.

SABS

$2.74 7.03%
Downtrend

Monopar Therapeutics Inc.

MNPR

$4.50 14.21%
Neutral

Adial Pharmaceuticals, Inc.

ADIL

$1.05 -2.78%
Downtrend

Pasithea Therapeutics Corp.

KTTA

$4.80 -17.24%
Downtrend

Quoin Pharmaceuticals, Ltd.

QNRX

$0.58 -0.84%
Downtrend

Better Therapeutics, Inc.

BTTX

$0.00 0.00%
Downtrend

ETF Exposure (2)

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

0%

$138.77 2.02%
Uptrend

Vanguard Extended Market Index Fund

VXF

0%

$182.92 2.00%
Uptrend